2019-nCoV Spike protein RBD (S477N) from MyBioSource.com

Supplier Page

Supplier Page from
MyBioSource.com for
2019-nCoV Spike protein RBD (S477N)

Get Pricing

Description

Recombinant 2019-nCoV Spike protein S1 subunit, RBD (S477N)(319-541) was expressed in CHO cells using a C-terminal his tag. The gene accession number is MN908947.
The receptor binding domain (RBD) of the SARS-CoV-2 spike glycoprotein that recognizes the host ACE2 receptor is a major determinant of viral entry and neutralization, and is also the most divergent region (1). Within RBD of SARS-CoV-2, S447 is the most commonly mutated residue and S477N mutation occurs very frequently alongside the D614G variant. MD simulation studies suggest that S477N strengthens the binding of the SARS-COV-2 spike with the hACE2 receptor (2). Hence, as the new variants displace the first-wave virus, it is pivotal to evaluate their transmissibility, virulence and their possible tendency to escape antibody neutralization (3)